Home > Insider Trading > Filing (0001437749-21-014606)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
72444	Vaxart Inc.	VXRT	Biological Products, (No Disgnostic Substances) (2836)	591212264

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1530193	Margaret Echerd	C/O Vaxart, Inc. 170 Harbor Way, Suite 300 South San Francisco CA 94080	Svp, Principal Accntng Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-09	12,333	$5.17	12,333	No	4	M	Direct
Common Stock	Acquisiton	2021-06-09	35,222	$0.77	47,555	No	4	M	Direct
Common Stock	Disposition	2021-06-09	47,555	$8.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-06-09	12,333	$0.00	12,333	$5.17
Common Stock	Stock Option (right to buy)	Disposition	2021-06-09	35,222	$0.00	35,222	$0.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,667		2028-05-24	No	4	M	Direct
35,222		2029-06-11	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of April 9, 2018, and the remaining shares in 36 equal monthly installments thereafter.
The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.